|
Featured Advertisers
Advertisers may not offer the brands, products or services featured on this page |
|
ArteFill® is FDA approved for use as a facial filler to treat only the nasolabial folds, or "smile lines". For patients with deep furrows or creases, ArteFill can replace the use of temporary fillers and save the patient time and money by eliminating the need for regular treatments. 
If you have not had an injectable filler in the past, your doctor may recommend a temporary filler first in order to determine the best placement and amount of volume for your needs. Other fillers include Juvederm, Restylane, Perlane, Sculptra, Radiesse.
ArteFill is often combined with Botox and temporary fillers to achieve a complete non-surgical facelift, sometimes referred to as the Injectable Facelift or the VolumaLift. ArteFill technology is based on both proprietary precision-filtered injectable microspheres and purified bovine collagen. ArteFill received FDA approval in November of 2006. ArteFill can permanently eliminate unsightly lines and wrinkles, leaving the skin looking younger, radiant, and revitalized. Effects look extremely natural. 
Generally, there is virtually no discomfort at all at the time of the ArteFill or Artecoll treatment. Rarely, there is some mild stinging for a day or two afterward. PMMA, the technology behind the microspheres, has been used in medicine and dentistry for over 30 years and has been left inside thousands of patients as bone cement and in other forms for many years with no allergies or any harmful effects. Collagen has also been used for decades with no proof of any health risk. Rarely, as with any filler substance, irregularities have been reported which are normally readily treatable. Allergy testing is required for Artefill, usually by a tiny forearm injection and followed by a 30 day waiting period to confirm that you are not allergic to Artefill. 
Related Stories about Allentown ArteFill:
Move Over, Popular Beauty Fillers--Here Comes Evolence® - SKINTASTIC™ is pleased to announce the arrival of newly FDA-approved Evolence®--the latest injectable collagen filler in the Skintastic arsenal of little- or no-downtime beauty treatments. EVOLENCE® utilizes highly-purified porcine Type I collagen, regarded as a preferred medical grafting substance due to its nearly identical similarity to human collagen.
Artefill Study Shows Positive Results - Interim results of a five year study on Artefill indicate that patients are, for the most part, satisfied with their treatment outcome and very few adverse events have been reported.
Physician Reports Positive Results with Artefill - The long lasting filler Artefill is seeing some positive results in an ongoing patient study for nasolabial fold correction.
MD Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler - Artefill proven to deliver patients a solution for younger, natural and smoother looking skin.
Artes Medical, Inc. - Announces Completion of Artefill Skin Test Study - Artes Medical Announces Completion of Enrollment and Treatment in ArteFill Skin Test Study
Artes Medical Announces Winner of ArteFill Face Forward Makeover Contest - Ohio Woman Undergoes Transformation Into Runway-Worthy Modern Mom
Artes Medical Initiates Market Launch and Commercial Sale of Elevess, a New FDA-Approved Hyaluronic Acid-Based Dermal Filler - "The Feel Good Filler" Delivers Comfort, Affordability, and Immediate Results
Artes Medical Reports Growing Demand for ArteFill with More Than Ten Thousand Patients Treated - ArteFill, the first and only FDA-approved non-resorbable injectable dermal filler, provides patients and doctors with a long-lasting solution for the correction of nasolabial folds, or "smile line" wrinkles.
Artes Medical Broadens Product Portfolio Through Exclusive U.S. Sales and Marketing Agreement for Elevess, a New FDA-Approved Hyaluronic Acid-Based Dermal Filler - Through this agreement, Artes Medical’s dedicated sales force will market and sell Elevess, the first FDA-approved HA dermal filler for the temporary correction of facial wrinkles that is formulated with an anesthetic for patient comfort, as well as the company’s flagship product, ArteFill, the first and only FDA-approved non-resorbable wrinkle filler for long-lasting correction of smile line wrinkles
Artes Medical Launches “The ArteFill Face Forward Makeover Contest: Celebrating Women’s Changing Lives” - Artes Medical, Inc. (Nasdaq:ARTE), maker of the long-lasting dermal filler ArteFill®, is celebrating women’s changing lives with the ArteFill Face Forward Makeover Contest. Women age 35 and over are invited to submit personal stories about a current or upcoming time of personal change. Four winners, selected by a panel of judges, will be honored with makeovers worth approximately $10,000
Non-Surgical Nose Job Shown on Fox Channel 10 in Phoenix - Using the permanent facial filler ArteFill, a doctor performs a live demonstration on the tv news of a non-surgical nose shaping procedure.
Dermatologic Surgery Journal Publishes Comparison of Global PMMA-Based Dermal Fillers Showing Superior Characteristics of ArteFill Microspheres - This newly published study evaluated five different PMMA products available over the past several years in the U.S. (one product), Europe (one product), Brazil (two products) and Canada (one product) for PMMA microsphere size and morphology using Scanning Electron Microscope (SEM) techniques. Each of the five products was evaluated with respect to PMMA microsphere size, homogeneity and surface characteristics. Results from the comparison show marked differences with respect to PMMA microsphere size and morphology. Products obtained from various markets outside the U.S. over time contained variable PMMA particle sizes with shape and surface irregularities, whereas the U.S. product, ArteFill, demonstrated round, smooth, uniformly sized particles.
Chicago Podiatrist Initiates Clinical Study to Evaluate ArteFill for Podiatric Disorder - The clinical study investigator, Mary Olszewski, DPM, American Board of Podiatric Orthopedic & Primary Podiatric Medicine, reports that she is conducting this study to evaluate ArteFill for the reduction of pain and impact on activity level caused by fat pad loss in the plantar metatarsal area in patients who have pain in their feet and who have failed the use of traditional conservative therapies such as pads, shoe wear, orthotics and /or possible use of other temporary injectable dermal filler materials.
|
©2002-2012 American Health And Beauty, LLC
Contact Us | Terms of Use |
